• Ligand, Emergent BioSolutions Tie Up for OmniAb Technology

    Source: NASDAQ International / 14 Jan 2016 17:52:54   America/New_York

    Ligand Pharmaceuticals IncorporatedLGND announced that it has entered into a worldwide license agreement with Emergent BioSolutions, Inc. EBS under which the latter will use the OmniRat, OmniMouse and OmniFlic technologies for the discovery of fully human mono and bispecific http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/AJofhPTLgxI/ligand-emergent-biosolutions-tie-up-for-omniab-technology-cm565991
Share on